Skip to Main Content

Paper Details

Unplanned 30-Day Readmission Rates for Autosomal Dominant Polycystic Kidney Disease: Insight from the Nationwide Readmissions Database.
Blood Purif
0
2022
ADPKD, Autosomal Dominant Polycystic Kidney Disease, ESKD, autosomal dominant polycystic kidney disease, end-stage kidney disease, patients
Author NameAffiliation
Girish N NadkarniThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
Girish N NadkarniThe Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai
Girish N NadkarniIcahn School of Medicine at Mount Sinai
Girish N NadkarniIcahn School of Medicine at Mount Sinai
Girish N NadkarniThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
Girish N NadkarniIcahn School of Medicine at Mount Sinai
Girish N NadkarniIcahn School of Medicine at Mount Sinai
Girish N NadkarniThe Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai
Lili ChanThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
Lili ChanIcahn School of Medicine at Mount Sinai
Lili ChanIcahn School of Medicine at Mount Sinai
  • 1 - 11

Datasets

Release 1.2